Search
Fibrobiologics Inc
FBLGAdd to Watchlist
1.430USD
-0.055-3.70%
Market hours 09/18, 12:18（ET）
8.70MMarket Cap
LossP/E TTM
More Details of Fibrobiologics Inc Company
FibroBiologics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis and certain cancers, and potential human longevity applications including thymic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). It is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat multiple sclerosis (MS) and has completed the Phase I study. It is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing. Its CYPS317 is used for the treatment of Psoriasis.
Fibrobiologics Inc Profile
Ticker SymbolFBLG
Company nameFibrobiologics Inc
IPO dateJan 31, 2024
CEOO'Heeron (Pete)
Number of employees13
Security typeOrdinary Share
Fiscal year-endJan 31
Address455 E. Medical Center Blvd
CityHOUSTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code77598
Phone12816715150
Websitehttps://fibrobiologics.com/
Ticker SymbolFBLG
IPO dateJan 31, 2024
CEOO'Heeron (Pete)
Company Executives of Fibrobiologics Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
3.06K
--
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
3.06K
--
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
3.06K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
375.00
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
375.00
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
375.00
--
Dr. Victoria Niklas, M.D.
Dr. Victoria Niklas, M.D.
Independent Director
Independent Director
--
--
Mr. Richard Cilento, Jr.
Mr. Richard Cilento, Jr.
Independent Director
Independent Director
--
--
Ms. Stacy Coen
Ms. Stacy Coen
Independent Director
Independent Director
--
--
Mr. Pete O'Heeron
Mr. Pete O'Heeron
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
3.06K
--
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
3.06K
--
Dr. Hamid Khoja, Ph.D.
Dr. Hamid Khoja, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
3.06K
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
375.00
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
375.00
--
Mr. Robert E. Hoffman, CPA
Mr. Robert E. Hoffman, CPA
Independent Director
Independent Director
375.00
--
FAQs
Who are the top five shareholders of Fibrobiologics Inc?
The top five shareholders of Fibrobiologics Inc are: Dr. Hamid Khoja, Ph.D.
How many institutions hold shares of Fibrobiologics Inc (FBLG)?
As of 2026Q1, 139 institutions hold shares of Fibrobiologics Inc, with a combined market value of approximately 258.88K, accounting for 4.97% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -83813.00.